Pyridoxamine improves metabolic and microcirculatory complications associated with nonalcoholic fatty liver disease

ConclusionPyridoxamine modulates oxidative stress, advanced glycation end products, TNF ‐α transcripts levels, and metabolic disturbances, being a potential treatment for nonalcoholic fatty liver disease‐associated microcirculatory and metabolic complications.

Source: Microcirculation - January 13, 2020 Category: Research Authors: Evelyn Nunes Goulart da Silva Pereira, Raquel Rangel Silvares, Edgar Eduardo Ilaquita Flores, Karine Lino Rodrigues, Anissa Daliry Tags: ORIGINAL ARTICLE Source Type: research